Cargando…
The Diagnostic Value of Anti-Parietal Cell and Intrinsic Factor Antibodies, Pepsinogens, and Gastrin-17 in Corpus-Restricted Atrophic Gastritis
We aimed to determine the diagnostic value of anti-parietal cell antibodies (anti-PCA), anti-intrinsic factor antibodies (anti-IFA), pepsinogen ratio (PGI/II), and gastrin-17 (G-17) in corpus-restricted atrophic gastritis (CRAG) detected by ELISA (Inova, Biohit). Our study compared 29 CRAG cases aga...
Autores principales: | Kriķe, Petra, Shums, Zakera, Poļaka, Inese, Kikuste, Ilze, Vanags, Aigars, Tolmanis, Ivars, Isajevs, Sergejs, Liepniece-Karele, Inta, Santare, Daiga, Tzivian, Lilian, Rudzīte, Dace, Song, Minkyo, Camargo, M. Constanza, Norman, Gary L., Leja, Mārcis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689963/ https://www.ncbi.nlm.nih.gov/pubmed/36428844 http://dx.doi.org/10.3390/diagnostics12112784 |
Ejemplares similares
-
Assessment of Serum Pepsinogens with and without Co-Testing with Gastrin-17 in Gastric Cancer Risk Assessment—Results from the GISTAR Pilot Study
por: Robles, Claudia, et al.
Publicado: (2022) -
Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study
por: Leja, Marcis, et al.
Publicado: (2017) -
Who Could Be Blamed in the Case of Discrepant Histology and Serology Results for Helicobacter pylori Detection?
por: Skrebinska, Sabine, et al.
Publicado: (2022) -
Factors Associated with False Negative Results in Serum Pepsinogen Testing for Precancerous Gastric Lesions in a European Population in the GISTAR Study
por: Razuka-Ebela, Danute, et al.
Publicado: (2022) -
Prevalence of Atrophic Gastritis in Kazakhstan and the Accuracy of Pepsinogen Tests to Detect Gastric Mucosal Atrophy
por: Mezmale, Linda, et al.
Publicado: (2019)